PFS Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.9K Hold
330
– – 0.02% 188
2026
Q2
$49.5K Hold
330
– – 0.02% 203
2026
Q1
$30.5K Hold
330
– – 0.01% 241
2025
Q4
$33.7K Hold
330
– – 0.02% 221
2025
Q3
$20.6K Buy
+330
New +$18K 0.01% 266

Other funds holding GH

PFS Partners's GH Position: Q3 2026 in Review

PFS Partners held its Guardant Health (GH) position steady in Q3 2026 at 330 shares worth $58.9K. The position accounts for 0.02% of the portfolio, ranked #188.

PFS Partners first reported a position in GH in Q3 2025 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • PFS Partners held 330 shares of Guardant Health worth $58.9K as of Q3 2026.
  • PFS Partners left its Guardant Health share count unchanged in Q3 2026.
  • Guardant Health made up 0.02% of PFS Partners's portfolio in Q3 2026, its #188 holding.
  • PFS Partners first reported a position in Guardant Health in Q3 2025 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on PFS Partners's 13F filing for Q3 2026, filed 21 Oct 2026.